---
schema_version: "secwatch.filing_event.v1"
accession: "0001653477-25-000011"
form_type: "8-K"
ticker: "NGVT"
cik: "0001653477"
company_name: "Ingevity Corp"
filed_at: "2025-02-18T23:59:59+00:00"
generated_at: "2026-05-26T16:36:44.279599+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ingevity Q4 net sales down 20% YoY to $298.8M; full-year net loss $430.3M

## Summary
- Q4 net sales $298.8M (-20% YoY); adjusted EBITDA $80.6M (margin 27.0%); net income $16.6M includes $23.4M restructuring charges.
- Full-year net sales $1.4B (-17% YoY); net loss $430.3M on $688M pre-tax charges in Performance Chemicals; adjusted EPS $3.51.
- 2025 guidance: sales $1.3B-$1.4B, adjusted EBITDA $400M-$415M, free cash flow $220M-$260M.
- In January 2025, began exploring strategic alternatives for Performance Chemicals Industrial Specialties line and North Charleston CTO refinery.
- Q4 operating cash flow $64.5M included final $50M termination fee payment from a long-term CTO supply agreement.

## SEC filing metadata
- accession: 0001653477-25-000011
- form_type: 8-K
- ticker: NGVT
- cik: 0001653477
- company_name: Ingevity Corp
- filed_at: 2025-02-18T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1653477/000165347725000011/0001653477-25-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1653477/000165347725000011/ngvt-20250218.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001653477-25-000011
- JSON: https://secwatch.observer/filing/0001653477-25-000011.json
- Plain text: https://secwatch.observer/filing/0001653477-25-000011.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.